Precision BioSciences (DTIL) Director Frankel Stanley Buys 1,000 Shares

What Happened
Frankel Stanley, a director of Precision BioSciences (DTIL), acquired 1,000 shares in an open-market purchase on 2026-09-28 at $6.00 per share, for a total transaction value of $6,000. The transaction was reported on an SEC Form 4 filed on 2026-09-30.

Key Details

• Transaction date: 2026-09-28
• Transaction type/code: Open-market purchase (P)
• Price per share: $6.00; total value: $6,000
• Form 4 filing date: 2026-09-30 — filed two days after the trade (appears timely under the two-business-day rule)
• Shares owned after transaction: not disclosed in the provided filing details
• Footnotes/plan: no 10b5-1 plan, tax-withholding, or other footnotes noted in the supplied data

Context
This was a straightforward open-market purchase (no option exercise, grant, or gift). The purchase amount is relatively small, so while insider buys can attract investor interest, the size of this transaction limits how strongly it should be interpreted as a signal about management’s view.